FDA OTC labeling rule crowds out "important consumer information" -- CTFA.
This article was originally published in The Rose Sheet
Executive Summary
FDA OTC LABEL RULE WOULD EXCLUDE "IMPORTANT CONSUMER INFORMATION," CTFA said, including claims such as non-comedo-genic, PABA free and fragrance free. Addressing FDA's Nonprescription Drugs Advisory Committee on the issue of FDA's proposed OTC label reform rule July 14, Cosmetic, Toiletry & Fragrance Association Assistant General Counsel Stephen Gettings maintained that "other important consumer information that's not required by any government agency," but is included on cosmetics packaging, is not accounted for under FDA's proposed labeling reg. These claims would be crowded out of labeling due to the amount of information required within a rigid template under the agency's proposal, CTFA asserted.